focus -WSS

focus

author：focus 2025-09-30 00:47:19 - browse：484

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Wikipedia

WSS

Even great ERs can’t make up for American health disparities

FDA drug safety: Singulair case shows systemic surveillance flaws

Covid misinformation case heads to Supreme Court

Novo Nordisk to expand supply of Wegovy for U.S. patients

Quicker fix for pulse oximeters urged during FDA public meeting

General Catalyst, Summa Health deal will turn on physician buy

hotspot

focus

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Brain 'hot spot' may explain why African Americans feel greater pain

Sports medicine is finally prioritizing gender equality

Woodcock on FDA’s accelerated approval and her next chapter

Jerome Adams on the need for new antivirals for Covid

FDA drug safety: Singulair case shows systemic surveillance flaws

Hepatitis C has a cure — but many Americans still lack access to it

SAMSHA loosens regulations on methadone treatment centers

Medical records are filled with copy

Option Care buys Amedisys in $3.6 billion home care deal

Wikipedia

RaDonda Vaught case: a double standard for nurses, physicians

Some dementia cases could be undiagnosed liver disease

Did the public have the right to know Arthur Ashe had AIDS?

General Catalyst, Summa Health deal will turn on physician buy

Commercial surrogacy can be ethical, despite pope’s claims

Cognito secures funding to test medical device for Alzheimer's

explore

Wikipedia

entertainment

focus